ABSTRACT & COMMENTARY

Risk-Reducing Surgery and Quality of Life for Patients with Breast and Ovarian Cancer

Name: Relias Media
Price range: $

September 1, 2023

Risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) for patients at high risk of breast and ovarian cancer led to decreased cancer-related distress, unaffected health-related quality of life, poorer body image after RRM, and decreased sexual function and increased menopause symptoms after RRSO.

Issue Date: September 1, 2023

Table of Contents

Dr. Rebecca H. Allen (editor) reports that she receives grant/research support from Bayer. The relevant financial relationship listed for this individual has been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements